{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:41:52Z","timestamp":1757313712609},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.trsl.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T23:46:41Z","timestamp":1467676001000},"page":"29-37.e1","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Deleterious effects of interruption followed by reintroduction of enzyme replacement therapy on a lysosomal storage disorder"],"prefix":"10.1016","volume":"176","author":[{"given":"Ana Paula","family":"Schneider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Matte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Pasqualim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Maria Vicente","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Quoos","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziela","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Regla","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2016.05.002_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/2326409813517663","article-title":"Lysosomal storage diseases","volume":"2","author":"Alroy","year":"2014","journal-title":"J Inborn Errors Metab Screen"},{"key":"10.1016\/j.trsl.2016.05.002_bib2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/B978-0-444-59565-2.00055-1","article-title":"Enzyme replacement therapy and substrate reduction therapy in lysosomal storage disorders with neurological expression","volume":"113","author":"Valayannopoulos","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.trsl.2016.05.002_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymgme.2013.03.005","article-title":"Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice","volume":"109","author":"Baldo","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2016.05.002_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1309\/AJCPFVSAEGO67NGT","article-title":"Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement","volume":"140","author":"Lebel","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.trsl.2016.05.002_bib5","doi-asserted-by":"crossref","first-page":"e0117271","DOI":"10.1371\/journal.pone.0117271","article-title":"Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type I","volume":"10","author":"Pasqualim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.05.002_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13023-015-0305-y","article-title":"The quality of economic evaluations of ultra-orphan drugs in Europe\u2014a systematic review","volume":"10","author":"Sch\u00fcller","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.trsl.2016.05.002_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10545-006-0237-8","article-title":"Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I","volume":"29","author":"Anbu","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.trsl.2016.05.002_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2012_158","article-title":"Did the temporary shortage in supply of imiglucerase have clinical consequences? Retrospective observational study on 34 Italian Gaucher type I patients","volume":"7","author":"Deroma","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.trsl.2016.05.002_bib9","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.05.002_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymgme.2014.12.301","article-title":"Shotgun proteomics reveals possible mechanisms for cognitive impairment in mucopolysaccharidosis I mice","volume":"114","author":"Baldo","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2016.05.002_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbr.2012.04.051","article-title":"Evidence of a progressive motor dysfunction in mucopolysaccharidosis type I mice","volume":"233","author":"Baldo","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.trsl.2016.05.002_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2016.05.002_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11095-014-1508-y","article-title":"Laronidase-functionalized multiple-wall lipid-core nanocapsules: promising formulation for a more effective treatment of mucopolysaccharidosis type I","volume":"32","author":"Mayer","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.trsl.2016.05.002_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bcmd.2010.05.001","article-title":"Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply","volume":"46","author":"Zimran","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.trsl.2016.05.002_bib15","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/ajmg.a.31831","article-title":"Rapid deterioration of a patient with mucopolysaccharidosis type I during interruption of enzyme replacement therapy","volume":"143A","author":"Wegrzyn","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2016.05.002_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2009.10.175","article-title":"Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice","volume":"99","author":"Langford-Smith","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2016.05.002_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2014.10.017","article-title":"First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient","volume":"114","author":"Fox","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2016.05.002_bib18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.trsl.2016.05.002_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.09.008","article-title":"High-dose enzyme replacement therapy in murine Hurler syndrome","volume":"111","author":"Ou","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2016.05.002_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.beem.2015.01.006","article-title":"The role of antibodies in enzyme treatments and therapeutic strategies","volume":"29","author":"Bigger","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416300627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416300627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T14:51:21Z","timestamp":1536591081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524416300627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":20,"alternative-id":["S1931524416300627"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2016.05.002","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deleterious effects of interruption followed by reintroduction of enzyme replacement therapy on a lysosomal storage disorder","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}